Trial Profile
A Randomised Controlled Pilot Trial of the Use of GnRH-antagonist Pituitary Suppression During Medicated Frozen-thawed Embryo Transfer (FET) Cycles
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 23 Apr 2019 Status changed from not yet recruiting to recruiting.
- 12 Dec 2018 New trial record